Ipsen (STU:I7G) Marketable Securities : €11 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Ipsen Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Ipsen's Marketable Securities for the quarter that ended in Dec. 2023 was €11 Mil.

Ipsen's annual Marketable Securities declined from Dec. 2021 (€42 Mil) to Dec. 2022 (€31 Mil) and declined from Dec. 2022 (€31 Mil) to Dec. 2023 (€11 Mil).

Ipsen Marketable Securities Historical Data

The historical data trend for Ipsen's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Marketable Securities Chart

Ipsen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

59.30

45.00

42.40

31.00

10.60

Ipsen Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Marketable Securities	Get a 7-Day Free Trial															42.40	46.10	31.00	24.70	10.60

Ipsen Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Ipsen (STU:I7G) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Ipsen Marketable Securities Related Terms

Thank you for viewing the detailed overview of Ipsen's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipsen (STU:I7G) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (STU:I7G) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

IPSEY:USA IPSEF:USA 0MH6:UK IPN:France I7G:Germany

Address

65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.

Ipsen (STU:I7G) Headlines

No Headlines